Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation

Leukemia Research
M LiuY Hayashi

Abstract

The expression of the p73 gene and the methylation status was examined in 61 acute lymphoblastic leukemia (ALL) cell lines and lymphocytes from seven healthy individuals. p73 mRNA was not expressed in 19 (31.1%) of 61 ALL cell lines, including 11 (31.4%) of 35 B-precursor ALL cell lines, 2 (16.7%) of 12 B-ALL/Burkitt lymphoma (BL) cell lines (totally 27.7% of B-lineage cell lines), 6 (42.9%) of 14 T-ALL cell lines, and expressed in all of normal lymphocytes, by reverse transcriptase-polymerase chain reaction (RT-PCR). Restriction-enzyme related PCR (REP) and methylation-specific PCR (MSP) revealed that the cell lines lacking p73 mRNA expression were hypermethylated. In contrast, normal lymphocytes and most cell lines that expressed detectable p73 mRNA were not hypermethylated with the exception of five cell lines. Furthermore, bisulfite genomic sequencing confirmed the results obtained by REP and MSP. Our results suggest that p73 inactivation may be involved in the pathogenesis of both T- and B-ALLs, and that hypermethylation is the predominant mechanism of inactivation of the p73 gene in ALL.

References

Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·J G HermanW M Linehan
Apr 22, 1993·Nature·A C Ferguson-SmithM A Surani
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Nov 6, 1998·The Journal of Experimental Medicine·V De LaurenziG Melino
Jun 11, 1999·Oncogene·H YoshikawaC C Harris
Feb 4, 2011·The American Journal of Clinical Nutrition·Romain Barres, Juleen R Zierath

❮ Previous
Next ❯

Citations

Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Shumin DongHo-keung Ng
Aug 4, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jing-Hong PeiWei-Xin Hu
Jan 31, 2002·Trends in Genetics : TIG·Annie YangFrank McKeon
Jul 27, 2002·Cancer Letters·Laura J Rush, Christoph Plass
Feb 5, 2002·Biochimica Et Biophysica Acta·U M MollA Zaika
Aug 23, 2002·Seminars in Cancer Biology·John R Melki, Susan J Clark
Mar 17, 2006·Leukemia·A PlutaP Smolewski
Oct 16, 2004·International Journal of Hematology·Tomohiro Kinoshita
Jan 12, 2002·The American Journal of Pathology·Lisa Lai Ping SiuYok-Lam Kwong
Jan 15, 2005·Biochemical and Biophysical Research Communications·Geeta Ram Sahu, Bibhu Ranjan Das
Aug 24, 2011·Leukemia & Lymphoma·Bettina R BonnBirgit Burkhardt
Sep 28, 2002·International Journal of Cancer. Journal International Du Cancer·Beatriz Martinez-DelgadoJavier Benítez
May 29, 2002·Oncogene·Utz KrugH Phillip Koeffler
Aug 3, 2002·Oncogene·Martin Widschwendter, Peter A Jones
Oct 18, 2006·The Journal of Pathology·P J Coates
Dec 15, 2005·The Journal of Pathology·Angela A G van TilborgEllen C Zwarthoff
Apr 30, 2003·The Journal of Biological Chemistry·Veronica VellaJean Y J Wang
Nov 4, 2015·Molecular Cancer Research : MCR·Mehrnoosh TashakoriGuillermina Lozano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.